Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Leukostasis D018921 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Migraine without Aura D020326 1 associated lipids
Ileitis D007079 2 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Multiple Trauma D009104 2 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Contracture D003286 3 associated lipids
Toxemia D014115 3 associated lipids
Bronchial Diseases D001982 3 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Ileal Diseases D007077 3 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Brain Injuries D001930 4 associated lipids
Cluster Headache D003027 4 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Thrombocytosis D013922 4 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Viremia D014766 4 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Burns, Inhalation D002059 4 associated lipids
Shock, Traumatic D012774 4 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Strongylida Infections D017206 5 associated lipids
Liver Failure D017093 5 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Spasm D013035 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Colonic Diseases D003108 5 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Sneezing D012912 6 associated lipids
Thrombophilia D019851 6 associated lipids
Gliosis D005911 6 associated lipids
Heart Injuries D006335 6 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Ear Diseases D004427 7 associated lipids
Pelvic Pain D017699 7 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Klebsiella Infections D007710 7 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Conjunctivitis D003231 7 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Behcet Syndrome D001528 7 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Mucositis D052016 7 associated lipids
Bronchiectasis D001987 7 associated lipids
Agranulocytosis D000380 7 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Cholecystitis D002764 8 associated lipids
Arthus Reaction D001183 8 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Corneal Neovascularization D016510 8 associated lipids
Lupus Nephritis D008181 8 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Li X and Luo H [Advances in pharmacological study of Piper kadsura (Choisy) Ohwi]. 2002 Zhong Yao Cai pmid:14748373
Sibelius U et al. Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: role of lipid mediator synthesis and sensitivity to interleukin-10. 2002 Crit. Care Med. pmid:12394960
Teather LA et al. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats. 2002 Psychopharmacology (Berl.) pmid:12373444
Baker PR et al. Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases. 2002 Biochim. Biophys. Acta pmid:12379481
Barbuti A et al. Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12003807
Kolaczkowska E et al. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. 2002 Inflammation pmid:11989789
Claud EC et al. Platelet-activating factor regulates chloride transport in colonic epithelial cell monolayers. 2002 Pediatr. Res. pmid:12149490
Unno N et al. Single nucleotide polymorphism (G994-->T) in the plasma platelet-activating factor-acetylhydrolase gene is associated with graft patency of femoropopliteal bypass. 2002 Surgery pmid:12110797
Parker MA et al. Platelet-activating factor induces permeability transition and cytochrome c release in isolated brain mitochondria. 2002 J. Neurosci. Res. pmid:12111814
Ahamed J and Ali H Distinct roles of receptor phosphorylation, G protein usage, and mitogen-activated protein kinase activation on platelet activating factor-induced leukotriene C(4) generation and chemokine production. 2002 J. Biol. Chem. pmid:11934880
Chang HW et al. Platelet-activating factor acetylhydrolase activity in cerebrospinal fluid of children with acute systemic or neurological illness. 2002 Ann. Neurol. pmid:12112082
Ewer AK Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. 2002 Acta Paediatr Suppl pmid:12200892
Göggel R et al. Platelet-activating factor-induced pulmonary edema is partly mediated by prostaglandin E(2), E-prostanoid 3-receptors, and potassium channels. 2002 Am. J. Respir. Crit. Care Med. pmid:12204861
Bazan H and Ottino P The role of platelet-activating factor in the corneal response to injury. 2002 Prog Retin Eye Res pmid:12207945
Teather LA et al. Platelet-activating factor increases prostaglandin E(2) release from astrocyte-enriched cortical cell cultures. 2002 Brain Res. pmid:12133598
De Plaen IG et al. Endotoxin, but not platelet-activating factor, activates nuclear factor-kappaB and increases IkappaBalpha and IkappaBbeta turnover in enterocytes. 2002 Immunology pmid:12153521
Akisu M et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the generation of platelet-activating factor and leukotriene B4 in hypoxic-ischemic brain in young mice. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12468264
Li L et al. Antiplatelet aggregation activity of diterpene alkaloids from Spiraea japonica. 2002 Eur. J. Pharmacol. pmid:12163102
Sakai H et al. Nitric oxide-induced Cl- secretion in isolated rat colon is mediated by the release of thromboxane A2. 2002 J. Physiol. (Lond.) pmid:12181297
Roudebush WE et al. Embryonic platelet-activating factor: temporal expression of the ligand and receptor. 2002 J. Assist. Reprod. Genet. pmid:11958508
Benito E and Bosch MA Role of platelet-activating factor in phosphatidylcholine secretion in primary cultures of rat type II pneumocytes. 2002 Prostaglandins Other Lipid Mediat. pmid:12013527
Ottino P et al. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2. 2002 Exp. Eye Res. pmid:12014920
Michalis LK et al. Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes. 2002 Curr Med Res Opin pmid:12017208
Zimmerman GA et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. 2002 Crit. Care Med. pmid:12004251
Silva AR et al. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. 2002 J. Immunol. pmid:11937571
Tachibana A et al. Respiratory syncytial virus enhances the expression of CD11b molecules and the generation of superoxide anion by human eosinophils primed with platelet-activating factor. 2002 Intervirology pmid:11937770
Kingston JK et al. Measurement of the activation of equine platelets by use of fluorescent-labeled annexin V, anti-human fibrinogen antibody, and anti-human thrombospondin antibody. 2002 Am. J. Vet. Res. pmid:11939312
Deo DD et al. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. 2002 J. Biol. Chem. pmid:11940567
Strait RT et al. Pathways of anaphylaxis in the mouse. 2002 J. Allergy Clin. Immunol. pmid:11941316
Xu N et al. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells. 2002 Biochem. Biophys. Res. Commun. pmid:11944906
Downing SJ et al. Effect of platelet-activating factor on the electrophysiology of the human Fallopian tube: early mediation of embryo-maternal dialogue? 2002 Reproduction pmid:12361471
Donnard M et al. Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia. 2002 Stem Cells pmid:12351810
Leung SW et al. Platelet-activating factor enhanced the pressor response of endothelin-1. 2002 J. Cardiovasc. Pharmacol. pmid:12352314
Brewer C et al. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor. 2002 J. Neurochem. pmid:12354298
Marin V et al. Chemotactic agents induce IL-6Ralpha shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-alpha-converting enzyme (TACE) type. 2002 Eur. J. Immunol. pmid:12355450
Beauchamp MH et al. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy. 2002 Invest. Ophthalmol. Vis. Sci. pmid:12356842
Michibayashi T Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits. 2002 Int Angiol pmid:12384648
Haynes J and Obiako B Activated polymorphonuclear cells increase sickle red blood cell retention in lung: role of phospholipids. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:11748055
Shigematsu S et al. Bradykinin-induced proinflammatory signaling mechanisms. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12388246
Maul H et al. Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. 2002 Am. J. Obstet. Gynecol. pmid:12388958
Murohisa G et al. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. 2002 Liver pmid:12390475
Maniscalco M et al. Nitric oxide attenuates platelet-activating factor induced nasal airway plasma extravasation in healthy subjects. 2002 Eur. J. Clin. Invest. pmid:12423328
Ishii S et al. Platelet-activating factor receptor. 2002 Prostaglandins Other Lipid Mediat. pmid:12432946
Ueyama Y et al. Effects of bile acids on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced aberrant crypt foci and DNA adduct formation in the rat colon. 2002 J. Exp. Clin. Cancer Res. pmid:12636105
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
Breschi MC et al. Protective effect of silymarin in antigen challenge- and histamine-induced bronchoconstriction in in vivo guinea-pigs. 2002 Eur. J. Pharmacol. pmid:11864645
Tanaka Y et al. Anti-CD44 monoclonal antibody (IM7) induces murine systemic shock mediated by platelet activating factor. 2002 J. Autoimmun. pmid:11869042
Talvani A et al. Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. 2002 Infect. Immun. pmid:12117933
Hanada K et al. Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy. 2002 J. Exp. Med. pmid:11781362
Fonteh AN Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human neutrophils. Evidence for different arachidonate pools. 2002 Eur. J. Biochem. pmid:12153573
Ohshima N et al. Receptor-dependent metabolism of platelet-activating factor in murine macrophages. 2002 J. Biol. Chem. pmid:11786559
Stangl V et al. Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion. 2002 Cardiovasc. Res. pmid:11744010
Cheminade C et al. 1-O-alkylglycerols improve boar sperm motility and fertility. 2002 Biol. Reprod. pmid:11804958
Walterscheid JP et al. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. 2002 J. Exp. Med. pmid:11805144
Unno N et al. Association of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in Japanese. 2002 Ann. Surg. pmid:11807372
Johansson S et al. A neutrophil multitarget functional bioassay to detect anti-inflammatory natural products. 2002 J. Nat. Prod. pmid:11809061
Nagase T et al. Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway. 2002 Am. J. Respir. Crit. Care Med. pmid:11790655
Roudebush WE et al. Relationship between platelet-activating factor concentration in rhesus monkey (Macaca mulatta) spermatozoa and sperm motility. 2002 Am. J. Primatol. pmid:11793409
Chen WM et al. [Experimental study on inhibitory effect of rutin against platelet activation induced by platelet activating factor in rabbits]. 2002 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:12584792
McKenna DJ et al. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. 2001 Sep-Oct Altern Ther Health Med pmid:11565403
de Souza LJ et al. Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. 2001 Jul-Aug J. Gastrointest. Surg. pmid:11985976
Coker A et al. Is mannitol effective against platelet-activating factor (PAF)-induced liver damage in obstructive jaundice? 2001 Jul-Aug Hepatogastroenterology pmid:11490817
Dery RE et al. Inhibition of allergic inflammation by C-terminal peptides of the prohormone submandibular rat 1 (SMR-1). 2001 Jan-Mar Int. Arch. Allergy Immunol. pmid:11306968
Iwazaki S et al. FR128998 ameliorates liver injury in extended liver resection with ischemia in dogs. 2001 Jan-Feb Hepatogastroenterology pmid:11268964
Magai RM and Shukla SD Metabolic fate of [14C]-ethanol into endothelial cell phospholipids including platelet-activating factor, sphingomyelin and phosphatidylethanol. 2001 Jan-Feb J. Biomed. Sci. pmid:11173988
Denizot Y et al. Is there a role of platelet-activating factor in human lung cancer? 2001 Aug-Sep Lung Cancer pmid:11551414
Jolly S et al. Effect of intravenous platelet-activating factor on bovine pulmonary mast cells. 2001 Aug-Oct J. Comp. Pathol. pmid:11578122
Marathe GK et al. Oxidized LDL contains inflammatory PAF-like phospholipids. 2001 Apr-May Trends Cardiovasc. Med. pmid:11686003
Taylor R et al. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction. 2001 Clin. Sci. pmid:11352774
Hayashi J et al. Platelet-activating factor antagonist, SM-12502, attenuates experimental glomerular thrombosis in rats. 2001 Nephron pmid:11287764
Choi JH et al. Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans. 2001 J. Immunol. pmid:11290796
Marathe GK et al. Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver. 2001 J. Lipid Res. pmid:11290831
Kato M et al. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis. 2001 J Ocul Pharmacol Ther pmid:11327052
Caplan MS et al. Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model. 2001 Pediatr. Res. pmid:11328947
Bassi F et al. Detection of platelet-activating factor in gingival tissue surrounding failed dental implants. 2001 J. Periodontol. pmid:11210074
Ferland C et al. Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. 2001 J. Leukoc. Biol. pmid:11358986
Petty HR and Kindzelskii AL Dissipative metabolic patterns respond during neutrophil transmembrane signaling. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11248046
Clavijo LC et al. PAF increases vascular permeability without increasing pulmonary arterial pressure in the rat. 2001 J. Appl. Physiol. pmid:11133918
Ko TC et al. Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents. 2001 Bioorg. Med. Chem. Lett. pmid:11212091
Taggart DP Effects of a platelet-activating factor antagonist on lung injury and ventilation after cardiac operation. 2001 Ann. Thorac. Surg. pmid:11216754
McManus LM et al. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. 2001 J. Leukoc. Biol. pmid:11527989
Jerkić M et al. The mechanism of increased renal susceptibility to toxic substances in the elderly. Part I. The role of increased vasoconstriction. 2001 Int Urol Nephrol pmid:11989542
Kawaguchi A et al. Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity. 2001 Life Sci. pmid:11228102
Caplan MS and Jilling T The role of polyunsaturated fatty acid supplementation in intestinal inflammation and neonatal necrotizing enterocolitis. 2001 Lipids pmid:11724457
Kaul DK et al. Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature. 2001 Blood pmid:11698300
Casao MA et al. Promotion of platelet aggregation by sera from brucellosis patients with antiphosphatidylcholine antibodies. 2001 J. Med. Microbiol. pmid:11699593
Lendvai B et al. Platelet-activating factor evokes Ca2+ transients after the blockade of ryanodine receptor by dantrolene in RAW 264.7 macrophages. 2001 Neurochem. Res. pmid:11699928
Houghton TJ et al. Efficient assembly of the phomactin core via two different macrocyclization protocols. 2001 Org. Lett. pmid:11700095
Adams JM et al. Entry of gut lymph into the circulation primes rat neutrophil respiratory burst in hemorrhagic shock. 2001 Crit. Care Med. pmid:11700422
Stoddart NR et al. Exogenous platelet-activating factor stimulates cell proliferation in mouse pre-implantation embryos prior to the fourth cell cycle and shows isoform-specific stimulatory effects. 2001 Zygote pmid:11510473
Feldman C et al. Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro. 2001 Eur. Respir. J. pmid:11510782
Mooren FC et al. Decoupling of intracellular calcium signaling in granulocytes after exhaustive exercise. 2001 Int J Sports Med pmid:11510867
Hermoso M et al. Platelet activating factor increases ciliary activity in the hamster oviduct through epithelial production of prostaglandin E2. 2001 Pflugers Arch. pmid:11484763
Sachais BS Platelet-endothelial interactions in atherosclerosis. 2001 Curr Atheroscler Rep pmid:11487452
Jantan I et al. Inhibition of platelet-activating factor receptor binding by aporphine and phenanthrenoid alkaloids from Aromadendron elegans. 2001 Planta Med. pmid:11488464
Thomet OA et al. Role of petasin in the potential anti-inflammatory activity of a plant extract of petasites hybridus. 2001 Biochem. Pharmacol. pmid:11286996
Burke JR et al. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. 2001 J. Pharmacol. Exp. Ther. pmid:11408565
Shah BH et al. Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine. 2001 Exp. Mol. Med. pmid:11795484
Cao YZ et al. Selenium modulates 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) biosynthesis in bovine aortic endothelial cells. 2001 Antioxid. Redox Signal. pmid:11813988
den Dekker E et al. Biogenesis of G-protein mediated calcium signaling in human megakaryocytes. 2001 Thromb. Haemost. pmid:11686331